NFKB1 and neoplasm: In established tumors, NF-κB may also promote immunosuppression by increasing the levels of immunosuppressive cytokines (e.g., IL-10 and TGF-β) and recruiting myeloid-derived suppressor cells (MDSCs), thereby promoting tumor progression.